Category: Economics

Adding Up the Romantic and Philosophical Benefits of Provider Affiliations

In Bargain, Pete Townshend of The Who sings, “One and one don’t make two. One and one make… Read More

By David Burda January 12, 2022

4sight Friday | 2022 Healthcare Predictions | Is VBR Mostly Dead or Slightly Alive?

Read 1/7/2022 Edition here. Curated by David Burda, 4sight Health’s news editor and columnist. Columns here. Find 4sight Health… Read More

By David Burda January 7, 2022

Economics

Burda on Healthcare: Is Value-Based Reimbursement Mostly Dead or Slightly Alive?

One of my favorite scenes in The Princess Bride is when Miracle Max tells Inigo and Fezzik that… Read More

By David Burda January 6, 2022

Economics

Unfazed by Unbridled Medicare Advantage Spending

You know what’s a big number? 9.7 percent is a big number. That’s how much total national health… Read More

By David Burda January 5, 2022

COVID-19

What Revolutionary Healthcare Leaders Are Consuming: The Top 7 on 4sighthealth.com Since Mid-2021

Below find the top-consumed 4sight Health content from the second half of 2021, from your favorite revolutionary healthcare… Read More

By David Burda January 4, 2022

Deja Vu All Over Again: No In-Person JP Morgan Healthcare Conference

“Out of an abundance of caution and after careful consideration, we have decided to virtualize our 40th annual… Read More

By David W. Johnson December 16, 2021

Outcomes

Harm and a Foul for Low-Value Care

No harm, no foul. It’s an expression I’ve used countless times to shrug off a mistake by me… Read More

By David Burda December 15, 2021

4sight Friday | Bringing Value-Based Care to Rural Markets | Why Drug Affordability Matters | Disparities in Physician Compensation

Read 12/10/2021 Edition here. Curated by David Burda, 4sight Health’s news editor and columnist. Columns here. Find 4sight Health… Read More

By David Burda December 10, 2021

Economics

Why Prescription Drug Affordability Matters

It’s pretty safe to say that if I had taken better care of myself in my 30s, 40s… Read More

By David Burda December 8, 2021

Economics